 |
|
|
|
|
|
|
| Founded |
|
May 1, 1989 |
| Capital |
|
425 million yen (as of March, 2011) |
| Sales |
|
3,287 million yen (for the fiscal year ended March, 2011) |
| Shareholder |
|
ZEON Corporation 100% |
| Employees |
|
172 (as of March, 2011) |
| Head Office |
|
Shiba Park Building, 2-4-1
Shiba Kohen, Minato-ku, 105-0011 Tokyo, Japan
TEL: +81-3-3578-7727
FAX: +81-3-3578-7751 |
| Offices |
|
Plant: Takaoka, Toyama |
| Products |
|
Medical devices for cardiac/circulatory, digestive, urinary and intravenous
nutrition systems, and other devices. |
|
|
|
|
|
Original "XEMEX" brand
Representing ZEON MEDICAL EXCELLENCE
"Z" standing for ZEON was replaced with "X," to indicate
challenging the unknown, and including the sense of actively pursuing the
frontier of the medical device business. |
|
|
|
|
|
|
|
|
Zeon Medical launched operations on January 1, 1990 as an affiliated company
of ZEON Corporation, a polymer chemistry manufacturer. ZEON Corporation
has continued to develop medical devices utilizing innovative materials,
particularly biomaterials, produced by combining the company's exclusive
technologies. The ventricular artificial heart, a typical medical device
resulting from these efforts, was the first such product in the world to
obtain approval for manufacture from the former Ministry of Health and
Welfare (currently the Ministry of Health, Labor and Welfare) in January
1990.
Zeon Medical Inc. began operations in January of the same year to sell
these products. In July 1996, the export, research and development and
manufacturing operations of ZEON Corporation were transferred to Zeon Medical,
and Zeon Medical completed the establishment of an integrated system as
a highly respected and integrated medical device manufacturer. Since then,
the Company has been committed to expanding this field of business.
| 1979-1981 |
|
The Research and Development Center of ZEON Corporation started commercial
development of a ventricular artificial heart in response to a request
from University of Tokyo. Testing with animals started in collaboration
with University of Tokyo and ZEON Corporation. |
| 1982-1989 |
|
Nine clinical studies and 61 clinical trials implemented, primarily by
Nihon University, Tohoku University and Tokyo Women's Medical University. |
| May 1989 |
|
Zeon Medical Inc. founded as a domestic distribution company for medical
devices of ZEON Corporation |
| December 1989 |
|
Manufacturing of the ventricular artificial heat approved by the Central
Pharmaceutical Affairs Council of the Ministry of Health and Welfare. |
| January 1990 |
|
Zeon Medical Inc. launched operations. |
| May 1990 |
|
World's smallest external stationary pacemaker developed and marketed. |
| July 1996 |
|
Research, development, manufacturing and export operations of ZEON Corporation
transferred to Zeon Medical. |
| March 2002 |
|
Takaoka Medical Device Second Plant completed. |
| April 2004 |
|
ISO 13485 certification obtained. |
| May 2007 |
|
Research and development Center moved to Takaoka. |
|
|
|
|
|
|
|
|
